Artemis Investment Management LLP Horizon Therapeutics Public LTD CO Transaction History

Artemis Investment Management LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$86.42 - $109.81 $2.31 Million - $2.93 Million	-26,710 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$98.56 - $119.91 $461,556 - $561,538	-4,683 Reduced 14.92%	26,710 $2.88 Million
Q3 2021 Oct 26, 2021	SELL	$91.91 - $110.37 $157,809 - $189,505	-1,717 Reduced 5.19%	31,393 $3.44 Million
Q2 2021 Aug 04, 2021	BUY	$86.24 - $95.92 $1.57 Million - $1.75 Million	18,254 Added 122.87%	33,110 $3.1 Million
Q1 2021 Apr 28, 2021	SELL	$71.83 - $95.48 $21.6 Million - $28.8 Million	-301,296 Reduced 95.3%	14,856 $1.37 Million
Q4 2020 Jan 26, 2021	BUY	$67.0 - $84.39 $16.7 Million - $21 Million	249,084 Added 371.39%	316,152 $23.2 Million
Q3 2020 Oct 29, 2020	BUY	$55.23 - $79.93 $3.7 Million - $5.36 Million	67,068 New	67,068 $5.21 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

Stay updated on Artemis Investment Management LLP with notifications on news.